Influence of Older Age and Other Risk Factors on Pneumonia Hospitalization in Switzerland in the Pneumococcal Vaccine Era

Abstract

Background: Pneumococcal pneumonia is a disease of the extremes of age. However, as other traditional risk factors for pneumococcal pneumonia also increase with older age, it is unclear if older age itself should be an indication for pneumococcal vaccination. Therefore, we assessed the effect of age on risk for hospitalization for pneumonia and for pneumococcal pneumonia.Methods: Using a national hospitalization dataset, all patients ≥16 years hospitalized in a Swiss hospital with a diagnosis of pneumonia or pneumococcal pneumonia between 2002 and 2015 were included. Multivariable logistic regression analysis was used to test the association between age (≥50 or ≥65 years) and hospitalization for pneumonia or pneumococcal pneumonia after adjusting for pneumococcal vaccine indications. Similar analyses were performed for effect of age on length of stay (LOS) and mortality.Results: Among a total of 17,619,016 hospitalizations a diagnosis of pneumonia was present in 421,760 (2.4%) and a diagnosis of pneumococcal pneumonia in 21,610 (0.12%). Age ≥50 years (OR: 3.52 and 2.12, respectively; p for both <0.001) and age ≥65 years (OR: 2.98 and 1.80, respectively; p for both <0.001) as well as most Swiss pneumococcal vaccine indications were independent predictors of hospitalization with a pneumonia and pneumococcal pneumonia diagnosis, respectively. Older age with both age cut-offs were associated with increased LOS (≥50 years: aRR: 1.19 and 1.24, respectively; age ≥65 years: aRR: 1.60 and 1.20, respectively; p < 0.001 for all) and mortality (≥50 years: aOR: 4.73 and 2.84, respectively; age ≥65 years: aOR: 2.38 and 2.69, respectively, p < 0.001 for all) in patients with a pneumonia and pneumococcal pneumonia diagnosis, respectively. The effects of pneumococcal vaccine indications decreased with older age. The incidences of hospitalizations with a pneumonia diagnosis and a pneumococcal pneumonia diagnosis increased significantly from the pre-vaccine era to the PCV7 era and the PCV13 era (p for trend for both analyses <0.001).Conclusion: This study confirms the Swiss indications for pneumococcal vaccination as independent risk factors for pneumonia hospitalizations. Older age itself should be considered as an additional vaccine indication. Pneumonia and pneumococcal pneumonia in adults have increased despite pneumococcal vaccination in children.

Protective Face Mask Filter Capable of Inactivating SARS-CoV-2, and Methicillin-Resistant Staphylococcus aureus and Staphylococcus epidermidis

“…SARS-CoV-2 is the third coronavirus causing severe pneumonia [ 3 , 4 ], an infection of the lungs usually caused by bacteria and viruses [ 5 , 6 ]. The death risk of viral pneumonias can increase when co-infection can be caused by viruses in the setting of community-acquired bacterial pneumonia such as the lethal Streptococcus pneumoniae [ 7 , 8 , 9 , 10 ], with additional symptoms of bacterial pneumonia [ 11 ]. New pathogens, such as SARS-CoV-2, which can coexist with a broad range of other types of clinically relevant bacteria, including multidrug-resistant strains, constitute a real-life threat to humans.…”

Characteristics of viral pneumonia in the COVID-19 era: an update

“…A Swiss study enrolling patients ageing > 65 years with suspected CAP screened for viral pathogens by PCR analysis of nasopharyngeal swabs demonstrated the presence of a viral genome in 31% of the cases. Rhinovirus and Influenza A/B viruses were those most identified and evidence of both bacterial and viral infection was detected in about 10% of the cases [ 14 ]. Instead, a study including a large population of patients with viral pneumonia highlighted that an active cancer was a strong independent predictor of 30-day mortality [ 15 ].…”

No Harmful Effects of Steroids in Severe Exacerbations&nbsp;of COPD Associated With Influenza

“…This database provides a diagnosis list including one main diagnosis plus up to 50 additional diagnoses following the ICD-10 system for each hospitalisation in Switzerland since 1998. It therefore provides an accurate representation of the (hospitalised) Swiss population and has previously been used for similar analyses [21].…”